Package 70518-2001-0

{"route": ["ORAL"], "spl_id": "498b9935-da9e-bfd0-e063-6394a90ad676", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199890"], "spl_set_id": ["0366164b-1846-443d-9564-dbe52d8d9b65"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2001-0)", "package_ndc": "70518-2001-0", "marketing_start_date": "20190403"}, {"sample": false, "description": "100 POUCH in 1 BOX (70518-2001-1)  / 1 TABLET, FILM COATED in 1 POUCH (70518-2001-2)", "package_ndc": "70518-2001-1", "marketing_start_date": "20191210"}], "brand_name": "topiramate", "product_id": "70518-2001_498b9935-da9e-bfd0-e063-6394a90ad676", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-2001", "generic_name": "topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA078235", "marketing_category": "ANDA", "marketing_start_date": "20190403", "listing_expiration_date": "20271231"}